IMPaCT Research Projects
En el marco de la infraestructura IMPaCT se desarrollan diferentes proyectos aprobados en las ayudas para Proyectos de Investigación de Medicina Personalizada de Precisión de la Acción Estratégica en Salud del Instituto de Salud Carlos III, dotándola de mayor contenido y avance científico.
Axis 1. Predictive Medicine (COHORT Program)
Axis 2. Data Science (DATA Program)
Axis 3. Genomic Medicine (GENOMICA Program)
precision medicine projects
PMP24/00025
2024
CASTILLA Y LEÓN
Dr. María Díez Campelo
UMBRELLA-SUMMA LEGACY
PMPER24/00007
2026
ANDALUSIA, CANARY ISLANDS, CANTABRIA, CASTILLA LA MANCHA, CATALONIA, COMMUNITY OF VALENCIA, MADRID, BASQUE COUNTRY
Gisela Nogales Gadea and Arturo López Castel
Creation of an integral node for Myotonic Dystrophy type 1 in Spain: clinical registry, genomic, epigenomic and proteomic maps (DM1-Hub)
PMP24/00012
2024
MADRID
Fernando Rodríguez Artalejo and Óscar Zurriaga Llorens
Incorporation of clinical information from primary and hospital care in the IMPACT cohort: IMPACT-IC project
PMP24/00008
2025
MADRID
Esther García García-Esquinas / Maria José Sánchez
AMBISiON-IMPaCT: Enrichment of the IMPaCT cohort with ENVIRONMENTAL and Eye Health measures for preventive precision medicine
PMP21/00065
2022
ANDALUSIA, BALEARIC, CATALONIA, CIUDAD REAL, GALICIA, MADRID
María Jesús Arranz Calderón
Clinical-pharmacogenetic interventions in the child and adolescent population
PMP22/00030
2025
ANDALUSIA, CANTABRIA, CASTILLA LA MANCHA, CATALONIA, COMMUNITY OF VALENCIA, EXTREMADURA, BALEARIC ISLANDS, LA RIOJA, MADRID, BASQUE COUNTRY
Dr. Ferran Barbé Illa
Impact of Sleep Respiratory Disorder Management on the Control of Systemic Hypertension: METASLEEP Project
Therapeutic Targets and Biomarkers for Precision Medicine in MAFLD (PreMed-MAFLD)
PMP21/00085
2021
CATALONIA
Sergi Mas Herrero
FARMacogenetics Applied to Predict the Treatment Response of the First Psychotic Episode (FARMAPRED-PEP Project)
PMP22/00008
2022
CATALONIA
Rafael Artuch
UNIQUE. Implementation of a Pediatric Network for Personalised Medicine in rare pediatric diseases. A Pilot Project.
PMP22/00022
2022
MADRID
Pascual Sánchez-Juan
PMP-DEGESCO: Validation of a precision medicine tool based on online cognitive evaluation, genetic risk stratification and bloodbased biomarkers for identification of preclinical Alzheimer’s Disease.